Aehr Gross Profit from 2010 to 2024

AEHR Stock

USD 12.16 0.46 3.93%

Aehr Test Gross Profit yearly trend continues to be relatively stable with very little volatility. Gross Profit is likely to grow to about 34.2 M this year. Gross Profit is the profit Aehr Test Systems makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1997-08-31

Previous Quarter

8.4 M

Current Value

7.1 M

Quarterly Volatility

2.6 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Aehr Test financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aehr Test's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 1.5 M or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 5.26, Dividend Yield of 0.0 or PTB Ratio of 1.66. Aehr financial statements analysis is a perfect complement when working with Aehr Test Valuation or Volatility modules.

Check out the analysis of Aehr Test Correlation against competitors.

Latest Aehr Test's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Aehr Test Systems over the last few years. Gross profit is a required income statement account that reflects total revenue of Aehr Test Systems minus its cost of goods sold. It is profit before Aehr Test operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Aehr Test's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aehr Test's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 23.66 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Aehr Gross Profit Regression Statistics

	Arithmetic Mean	14,225,543
	Geometric Mean	10,965,564
	Coefficient Of Variation	77.53
	Mean Deviation	9,186,191
	Median	8,371,000
	Standard Deviation	11,028,727
	Sample Variance	121.6T
	Range	30.3M
	R-Value	0.69
	Mean Square Error	68.6T
	R-Squared	0.48
	Significance	0
	Slope	1,701,375
	Total Sum of Squares	1702.9T

Aehr Gross Profit History

	2024	34.2 M
	2023	32.5 M
	2022	32.7 M
	2021	23.7 M
	2020	6 M
	2019	8.4 M
	2018	7.6 M

Other Fundumenentals of Aehr Test Systems

Gross Profit Margin

Aehr Test Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Current Deferred Revenue	Short Term Investments	Common Stock	Property Plant Equipment	Net Tangible Assets	Total Permanent Equity	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Cash And Equivalents
Total Assets		1.0	-0.95	0.45	0.8	0.65	0.53	0.99	-0.12	-0.21	0.19	0.49	0.96	0.99	0.48	0.76	-0.02	0.25	0.98	0.97	0.95	0.89
Total Stockholder Equity	1.0		-0.96	0.45	0.76	0.62	0.46	0.98	-0.13	-0.24	0.14	0.48	0.95	0.99	0.46	0.75	-0.02	0.21	0.98	0.97	0.95	0.89
Net Debt	-0.95	-0.96		-0.31	-0.67	-0.62	-0.43	-0.95	0.15	0.1	0.01	-0.57	-0.83	-0.96	-0.51	-0.8	-0.02	-0.29	-0.92	-0.92	-0.92	-0.91
Retained Earnings	0.45	0.45	-0.31		0.42	0.19	0.23	0.4	0.09	-0.35	0.44	-0.42	0.49	0.37	-0.34	-0.05	-0.05	-0.18	0.54	0.52	0.34	0.3
Accounts Payable	0.8	0.76	-0.67	0.42		0.88	0.78	0.84	-0.03	-0.08	0.68	0.44	0.81	0.81	0.34	0.67	-0.07	0.11	0.73	0.79	0.84	0.79
Net Receivables	0.65	0.62	-0.62	0.19	0.88		0.71	0.72	-0.03	0.0	0.61	0.62	0.61	0.7	0.28	0.77	-0.11	-0.06	0.55	0.63	0.78	0.82
Total Liab	0.53	0.46	-0.43	0.23	0.78	0.71		0.58	0.01	0.26	0.67	0.5	0.55	0.52	0.38	0.62	-0.04	0.45	0.45	0.5	0.56	0.57
Total Current Assets	0.99	0.98	-0.95	0.4	0.84	0.72	0.58		-0.12	-0.14	0.25	0.54	0.94	1.0	0.49	0.79	-0.01	0.26	0.96	0.97	0.97	0.92
Short Term Debt	-0.12	-0.13	0.15	0.09	-0.03	-0.03	0.01	-0.12		-0.42	0.16	-0.02	-0.11	-0.14	-0.05	-0.08	0.61	0.02	-0.19	-0.25	-0.18	-0.22
Current Deferred Revenue	-0.21	-0.24	0.1	-0.35	-0.08	0.0	0.26	-0.14	-0.42		0.03	0.05	-0.31	-0.17	-0.04	-0.06	-0.14	0.37	-0.22	-0.14	-0.15	-0.06
Short Term Investments	0.19	0.14	0.01	0.44	0.68	0.61	0.67	0.25	0.16	0.03		-0.02	0.31	0.19	-0.16	0.12	-0.04	-0.18	0.13	0.21	0.24	0.22
Common Stock	0.49	0.48	-0.57	-0.42	0.44	0.62	0.5	0.54	-0.02	0.05	-0.02		0.43	0.55	0.74	0.92	0.07	0.29	0.35	0.37	0.57	0.59
Property Plant Equipment	0.96	0.95	-0.83	0.49	0.81	0.61	0.55	0.94	-0.11	-0.31	0.31	0.43		0.94	0.44	0.7	-0.09	0.17	0.94	0.93	0.9	0.8
Net Tangible Assets	0.99	0.99	-0.96	0.37	0.81	0.7	0.52	1.0	-0.14	-0.17	0.19	0.55	0.94		0.49	0.8	-0.02	0.21	0.96	0.97	0.97	0.92
Total Permanent Equity	0.48	0.46	-0.51	-0.34	0.34	0.28	0.38	0.49	-0.05	-0.04	-0.16	0.74	0.44	0.49		0.66	0.18	0.61	0.37	0.35	0.43	0.39
Capital Surpluse	0.76	0.75	-0.8	-0.05	0.67	0.77	0.62	0.79	-0.08	-0.06	0.12	0.92	0.7	0.8	0.66		-0.01	0.25	0.66	0.68	0.83	0.84
Deferred Long Term Liab	-0.02	-0.02	-0.02	-0.05	-0.07	-0.11	-0.04	-0.01	0.61	-0.14	-0.04	0.07	-0.09	-0.02	0.18	-0.01		0.21	-0.06	-0.11	-0.15	-0.15
Short Long Term Debt	0.25	0.21	-0.29	-0.18	0.11	-0.06	0.45	0.26	0.02	0.37	-0.18	0.29	0.17	0.21	0.61	0.25	0.21		0.23	0.21	0.17	0.16
Net Invested Capital	0.98	0.98	-0.92	0.54	0.73	0.55	0.45	0.96	-0.19	-0.22	0.13	0.35	0.94	0.96	0.37	0.66	-0.06	0.23		0.99	0.93	0.87
Net Working Capital	0.97	0.97	-0.92	0.52	0.79	0.63	0.5	0.97	-0.25	-0.14	0.21	0.37	0.93	0.97	0.35	0.68	-0.11	0.21	0.99		0.95	0.91
Capital Stock	0.95	0.95	-0.92	0.34	0.84	0.78	0.56	0.97	-0.18	-0.15	0.24	0.57	0.9	0.97	0.43	0.83	-0.15	0.17	0.93	0.95		0.97
Cash And Equivalents	0.89	0.89	-0.91	0.3	0.79	0.82	0.57	0.92	-0.22	-0.06	0.22	0.59	0.8	0.92	0.39	0.84	-0.15	0.16	0.87	0.91	0.97

Click cells to compare fundamentals

About Aehr Test Financial Statements

Aehr Test shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although Aehr Test investors may analyze each financial statement separately, they are all interrelated. The changes in Aehr Test's assets and liabilities, for example, are also reflected in the revenues and expenses on on Aehr Test's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	32.5 M	34.2 M
Gross Profit Margin	0.49	0.32

Pair Trading with Aehr Test

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.

Moving against Aehr Stock

0.45	ICHR	Ichor Holdings	Pair Corr
0.41	EHGO	Eshallgo Class A Downward Rally	Pair Corr
0.38	CWAN	Clearwater Analytics	Pair Corr
0.36	INTC	Intel Fiscal Year End 23rd of January 2025	Pair Corr

The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.

The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Aehr Stock Analysis

When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC